<SEC-DOCUMENT>0001104659-16-162852-index.html : 20161220
<SEC-HEADER>0001104659-16-162852.hdr.sgml : 20161220
<ACCEPTANCE-DATETIME>20161219173537
ACCESSION NUMBER:		0001104659-16-162852
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20161219
FILED AS OF DATE:		20161220
DATE AS OF CHANGE:		20161219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nabriva Therapeutics AG
		CENTRAL INDEX KEY:			0001641640
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37558
		FILM NUMBER:		162059798

	BUSINESS ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110
		BUSINESS PHONE:		43 (0)1 740 93-0

	MAIL ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a16-23188_26k.htm
<DESCRIPTION>6-K
<TEXT>
Document 1 - file: a16-23188_26k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>a16-23188_2ex3d1.htm
<DESCRIPTION>EX-3.1
<TEXT>
Document 2 - file: a16-23188_2ex3d1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>a16-23188_2ex5d1.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 3 - file: a16-23188_2ex5d1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>a16-23188_2ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 4 - file: a16-23188_2ex99d1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g231882kki001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g231882kki001.jpg

</DOCUMENT>
</SEC-DOCUMENT>